BIOFIRE® Blood Culture Identification 2 (BCID2), identifying 43 of the most common causes of bloodstream infections and associated antimicrobial resistances directly from positive blood culture.

bioMérieux, a world leader in the field of in vitro diagnostics, announces that BioFire Diagnostics, its molecular biology affiliate, has submitted to the Food and Drug Administration for 510 ...

BioFire Diagnostics, Inc. announced today that it obtained the CE IVD Mark under the European Directive on In Vitro Diagnostic Medical Devices for its ...

BioFire Diagnostics may have agreed to sell itself to French diagnostics giant bioMérieux for $450 million, but the company plans to keep its name and senior management and continue growing at ...

French diagnostics giant bioMérieux finalized its acquisition of U.S.-based BioFire Diagnostics on Thursday. Under the agreement, bioMérieux will pay $450 million and will also assume BioFire's ...

France-based bioMérieux has acquired the privately held US company, BioFire Diagnostics Inc for $400 million, consolidating its position as a major player in infectious disease diagnostics ...

Diagnostics company bioMerieux has reached an agreement to acquire molecular biology company BioFire Diagnostics for $450 million in a move intended to strengthen the French company’s position ...

BioFire Diagnostics Inc. has raised $25 million in new funding from New York-based Athyrium Opportunities Fund. The money will be used to help commercialize the company’s “FilmArray ...

For over two decades, BioFire Diagnostics has been a key player in Utah's health sciences community. Big changes are coming to BioFire's branding—but company leaders say nothing will change its ...

BioFire Diagnostics, Inc. today announced that it has signed a competitive prototyping contract with the Department of the Army for Increment 1 of the Next Generation Diagnostics System (NGDS ...

Regulatory News: bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, announces that BioFire Diagnostics, its molecular biolog ...